Clinical Trials

Breast Neoplasms, Neoplasm Metastasis

NCT07029399 2026-05-19

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Phase 1 Recruiting

361 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms, Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT07340619 2026-05-19

EPIBREAST

51 enrolled

Dermatologic

Melanoma, Neoplasm Metastasis

NCT06757634 2026-05-18

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Phase 3 Recruiting

1,180 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Neoplasm Metastasis

NCT06625775 2026-04-13

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Phase 1 Recruiting

392 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT06506955 2026-04-03

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

Phase 2/3 Enrolling by invitation

15 enrolled

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

NCT05735080 2026-04-01

INX-315-01

Phase 1/2 Recruiting

150 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT01560416 2026-03-03

Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

50 enrolled 14 charts

Breast Neoplasms, Neoplasm Metastasis

NCT01602380 2026-02-27

FALCON

Phase 3 Completed

462 enrolled 20 charts

Phase 3 Active not recruiting

Neoplasm Metastasis, Neoplasms

NCT05501886 2026-02-10

VIKTORIA-1

701 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT05933395 2026-01-20

GERTRUDE

Phase 2 Recruiting

135 enrolled

Phase 3 Active not recruiting

Neoplasm Metastasis

NCT05169567 2026-01-16

postMONARCH

368 enrolled 14 charts

Phase 2 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT04214288 2025-11-20

SERENA-2

240 enrolled 16 charts

Phase 1 Not yet recruiting

Neoplasm Metastasis

NCT07163481 2025-09-16

SoGreat

12 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04300790 2025-07-29

METALLICA

Phase 3 Active not recruiting

69 enrolled

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT04975308 2025-07-11

EMBER-3

874 enrolled 29 charts 1 FDA

Phase 1 Active not recruiting

Breast Neoplasms, Neoplasm Metastasis

NCT06253195 2025-06-05

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

33 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01441947 2025-05-25

Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

68 enrolled 11 charts

Breast Neoplasms, Neoplasm Metastasis

NCT03854903 2025-02-06

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Phase 1 Completed

19 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04738292 2024-05-03

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

Phase 2 Terminated

11 enrolled 10 charts

Neoplasm Metastasis

NCT01953926 2024-03-12

SUMMIT

Phase 2 Terminated

582 enrolled 27 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms

NCT02536742 2024-02-26

PYTHIA

124 enrolled 10 charts

Breast Neoplasms, Neoplasm Metastasis

NCT04707196 2023-11-24

A Study of Abemaciclib in Indian Women With Advanced Breast Cancer

Phase 4 Completed

200 enrolled 10 charts

Breast Neoplasms, Neoplasm Metastasis

NCT04901299 2023-08-01

HER2-Signal

Phase 2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis

NCT02894398 2023-03-13

INGE-B

388 enrolled

BreastLymphoidOther solid neoplasmThoracic

Breast Neoplasms, Neoplasm Metastasis

NCT02753686 2023-02-15

Treat ER+ight

Completed

440 enrolled

Endocrine

Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT01655225 2022-04-08

A Study of LY3023414 in Participants With Advanced Cancer

Phase 1 Completed

156 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

NCT03220178 2022-01-06

PRECYCLE

Phase 4 Terminated

532 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04498520 2021-05-18

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Phase 1 Withdrawn

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Carcinoma, Endometrioid

NCT01610284 2020-08-25

BELLE-2

Phase 3 Completed

1,147 enrolled 20 charts

Breast Neoplasms, Neoplasm Metastasis

NCT02690480 2020-02-05

FLIPPER

Phase 2 Unknown

189 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01633060 2019-01-30

BELLE-3

Phase 3 Terminated

432 enrolled 20 charts

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT03560856 2018-06-18

PALPETBIO

Phase 2 Unknown

54 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00752986 2016-12-05

ZACFAST

Phase 2 Terminated

39 enrolled 7 charts

Breast Neoplasms, Neoplasm Metastasis

NCT02383030 2016-06-15

FUMANCE

Phase 3 Unknown

156 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02404051 2016-06-15

FEVEX

Phase 3 Unknown

745 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT00534417 2013-02-01

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

41 enrolled 13 charts

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00241449 2012-06-06

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

Phase 3 Completed

51 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT01399086 2012-03-13

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

Completed

140 enrolled